Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023)
Talphera's (TLPH) quarterly Long-Term Debt Repayments came in at $3.3 million in Q2 2023, up 60.01% year-on-year from $2.1 million in Q2 2022, and up 60.01% quarter-over-quarter from $2.1 million in Q1 2023.
Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023) Analysis & Trends
Talphera's Long-Term Debt Repayments history runs 10 years deep, the most recent figure standing at $3.3 million for Q2 2023.
- On a quarterly basis, Long-Term Debt Repayments rose 60.01% year-over-year to $3.3 million in Q2 2023; TTM through Mar 2024 was $3.3 million, a 60.48% decrease from a year earlier, with the FY2023 full-year figure at $5.4 million, down 35.78% from the prior year.
- Long-Term Debt Repayments advanced to $3.3 million in Q2 2023 per TLPH's latest filing, from $2.1 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $3.3 million in Q2 2023 and bottomed at $1.4 million in Q2 2019.
- The 5-year median for Long-Term Debt Repayments is $2.1 million (2020), against an average of $2.2 million.
- Across the five-year window, Long-Term Debt Repayments retreated 25.96% in 2019 and jumped 60.01% in 2023, its largest moves.
- Year by year, Long-Term Debt Repayments stood at $1.4 million in 2019, then jumped by 48.22% to $2.1 million in 2020, then fell by 0.05% to $2.1 million in 2021, then gained by 4.8% to $2.2 million in 2022, then soared by 52.68% to $3.3 million in 2023.
- Per Business Quant, the three latest TLPH Long-Term Debt Repayments figures stand at $3.3 million (Q2 2023), $2.1 million (Q1 2023), and $2.2 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 23.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -478.39 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |